Seoul High Court rejected injunction ruling on 45 items

Pharmaceutical business sources say that the administrative litigation involving the reduction of reimbursement price of insurance drugs will take a new turning point, as Seoul High Court acknowledged on December 3rd the complaints of the health ministry on 23 items (six firms) having injunction rulings to suspend the government's price reduction and rejected the injunction complaint on 45 item...